Next Article in Journal / Special Issue
Voltage-Gated Calcium Channel Antagonists and Traumatic Brain Injury
Previous Article in Journal
How “Pharmacoresistant” is Cav2.3, the Major Component of Voltage-Gated R-type Ca2+ Channels?
Previous Article in Special Issue
Calcium Channel Blockers as Tocolytics: Principles of Their Actions, Adverse Effects and Therapeutic Combinations
Pharmaceuticals 2013, 6(6), 777-787; doi:10.3390/ph6060777

Notes on Article Versions

Action Date Notes Link
article pdf uploaded. 29 May 2013 15:39 CEST Version of Record http://www.mdpi.com/1424-8247/6/6/777/pdf
article xml file uploaded 13 September 2013 17:19 CEST Original file http://www.mdpi.com/1424-8247/6/6/777/xml
article html file updated 13 September 2013 17:19 CEST Original file -
article html file updated 17 June 2015 09:49 CEST Update http://www.mdpi.com/1424-8247/6/6/777/html
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert